These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 15342919)

  • 1. Stuck in the craw.Parkinson's proteins choke cell's recycling system.
    Leslie M
    Sci Aging Knowledge Environ; 2004 Sep; 2004(35):nf80. PubMed ID: 15342919
    [No Abstract]   [Full Text] [Related]  

  • 2. Lewy bodies in Parkinson's disease: protectors or perpetrators?
    Harrower TP; Michell AW; Barker RA
    Exp Neurol; 2005 Sep; 195(1):1-6. PubMed ID: 16023637
    [No Abstract]   [Full Text] [Related]  

  • 3. New hope for mechanism-based treatment of Parkinson's disease.
    Bradbury J
    Drug Discov Today; 2005 Jan; 10(2):80-1. PubMed ID: 15718152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Controversy: is Parkinson's disease a single disease entity? Yes.
    Takahashi H; Wakabayashi K
    Parkinsonism Relat Disord; 2005 Jun; 11 Suppl 1():S31-7. PubMed ID: 15885626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of alpha-synuclein in rat substantia nigra results in loss of dopaminergic neurons, phosphorylation of alpha-synuclein and activation of caspase-9: resemblance to pathogenetic changes in Parkinson's disease.
    Yamada M; Iwatsubo T; Mizuno Y; Mochizuki H
    J Neurochem; 2004 Oct; 91(2):451-61. PubMed ID: 15447678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene and protein signatures in sporadic Parkinson's disease and a novel genetic model of PD.
    Mandel SA; Fishman T; Youdim MB
    Parkinsonism Relat Disord; 2007; 13 Suppl 3():S242-7. PubMed ID: 18267243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nitrosative and oxidative stress links dysfunctional ubiquitination to Parkinson's disease.
    Gu Z; Nakamura T; Yao D; Shi ZQ; Lipton SA
    Cell Death Differ; 2005 Sep; 12(9):1202-4. PubMed ID: 16094397
    [No Abstract]   [Full Text] [Related]  

  • 8. The last decade in Parkinson's disease research. Basic sciences.
    Przedborski S; Vila M
    Adv Neurol; 2001; 86():177-86. PubMed ID: 11553976
    [No Abstract]   [Full Text] [Related]  

  • 9. Dopaminergic innervation of the human striatum in Parkinson's disease.
    Papapetropoulos S; Basel M; Mash DC
    Mov Disord; 2007 Jan; 22(2):286-8. PubMed ID: 17083095
    [No Abstract]   [Full Text] [Related]  

  • 10. A not entirely benign procedure: progression of Parkinson's disease.
    Del Tredici K; Braak H
    Acta Neuropathol; 2008 Apr; 115(4):379-84. PubMed ID: 18320198
    [No Abstract]   [Full Text] [Related]  

  • 11. The role of autophagy-lysosome pathway in neurodegeneration associated with Parkinson's disease.
    Pan T; Kondo S; Le W; Jankovic J
    Brain; 2008 Aug; 131(Pt 8):1969-78. PubMed ID: 18187492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How a cell deals with abnormal proteins. Pathogenetic mechanisms in protein aggregation diseases.
    Aigelsreiter A; Janig E; Stumptner C; Fuchsbichler A; Zatloukal K; Denk H
    Pathobiology; 2007; 74(3):145-58. PubMed ID: 17643060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease.
    Halliday GM; Ophof A; Broe M; Jensen PH; Kettle E; Fedorow H; Cartwright MI; Griffiths FM; Shepherd CE; Double KL
    Brain; 2005 Nov; 128(Pt 11):2654-64. PubMed ID: 16000336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The experimental models of Parkinson's disease in animals].
    Grigor'ian GA; Bazian AS
    Usp Fiziol Nauk; 2007; 38(4):80-8. PubMed ID: 18064910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The fate of striatal dopaminergic neurons in Parkinson's disease and Huntington's chorea.
    Huot P; Lévesque M; Parent A
    Brain; 2007 Jan; 130(Pt 1):222-32. PubMed ID: 17142832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levodopa delivery systems for the treatment of Parkinson's disease: an overview.
    Goole J; Amighi K
    Int J Pharm; 2009 Oct; 380(1-2):1-15. PubMed ID: 19651197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxidative damage in Parkinson's disease.
    Sherer TB; Greenamyre JT
    Antioxid Redox Signal; 2005; 7(5-6):627-9. PubMed ID: 15890006
    [No Abstract]   [Full Text] [Related]  

  • 18. A new road to neuroinflammation in Parkinson's disease?
    Fuxe KG; Tarakanov AO; Goncharova LB; Agnati LF
    Brain Res Rev; 2008 Aug; 58(2):453-8. PubMed ID: 18457883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Magnetic resonance spectroscopy in Parkinson's disease and parkinsonian syndromes.
    Rango M; Arighi A; Biondetti P; Barberis B; Bonifati C; Blandini F; Pacchetti C; Martignoni E; Bresolin N; Nappi G
    Funct Neurol; 2007; 22(2):75-9. PubMed ID: 17637209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The second brain and Parkinson's disease.
    Lebouvier T; Chaumette T; Paillusson S; Duyckaerts C; Bruley des Varannes S; Neunlist M; Derkinderen P
    Eur J Neurosci; 2009 Sep; 30(5):735-41. PubMed ID: 19712093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.